At Hastings Law Firm, we work closely with medical experts to build strong cases based on the latest scientific evidence, ensuring that we can effectively demonstrate the connection between Ozempic use and our clients vision issues
For many people, weight loss becomes more consistent during the second month
Cardiovascular and kidney outcomes In patients with diabetes, GLP-1s are now FDA-approved to reduce major adverse cardiac events (MACE) and slow chronic kidney disease progression
However, renal function must be monitored in patients with renal impairment who experience severe gastrointestinal adverse effects during treatment with albiglutide, dulaglutide, or lixisenatide because of the potential for dehydration (1618)
Recent epidemiological data indicate an overall incidence of MASLD ranging from 46.1 to 46.9 new cases per 1,000 person-years, with a prevalence estimated at 30.05% to 32.4%